Sheptide A: an antimalarial cyclic pentapeptide from a fungal strain in the Herpotrichiellaceae

Robert A. Shepherd,Cody E. Earp,Kristof B. Cank,Huzefa A. Raja,Joanna Burdette,Steven P. Maher,Adriana A. Marin,Anthony A. Ruberto,Sarah Lee Mai,Blaise A. Darveaux,Dennis E. Kyle,Cedric J. Pearce,Nicholas H. Oberlies
DOI: https://doi.org/10.1038/s41429-023-00655-6
2023-09-21
The Journal of Antibiotics
Abstract:As part of ongoing efforts to isolate biologically active fungal metabolites, a cyclic pentapeptide, sheptide A ( 1 ), was discovered from strain MSX53339 ( Herpotrichiellaceae ). The structure and sequence of 1 were determined primarily by analysis of 2D NMR and HRMS/MS data, while the absolute configuration was assigned using a modified version of Marfey's method. In an in vitro assay for antimalarial potency, 1 displayed a pEC 50 value of 5.75 ± 0.49 against malaria-causing Plasmodium falciparum . Compound 1 was also tested in a counter screen for general cytotoxicity against human hepatocellular carcinoma (HepG2), yielding a pCC 50 value of 5.01 ± 0.45 and indicating a selectivity factor of ~6. This makes 1 the third known cyclic pentapeptide biosynthesized by fungi with antimalarial activity.
pharmacology & pharmacy,immunology,biotechnology & applied microbiology,microbiology
What problem does this paper attempt to address?